CA2632702A1 - Polypeptides secretes transmembranaires et acides nucleiques codant pour ceux-ci - Google Patents

Polypeptides secretes transmembranaires et acides nucleiques codant pour ceux-ci Download PDF

Info

Publication number
CA2632702A1
CA2632702A1 CA002632702A CA2632702A CA2632702A1 CA 2632702 A1 CA2632702 A1 CA 2632702A1 CA 002632702 A CA002632702 A CA 002632702A CA 2632702 A CA2632702 A CA 2632702A CA 2632702 A1 CA2632702 A1 CA 2632702A1
Authority
CA
Canada
Prior art keywords
acid sequence
pro
seq
nucleic acid
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002632702A
Other languages
English (en)
Inventor
Kevin P. Baker
Dan L. Eaton
Ellen Filvaroff
Sherman Fong
Audrey Goddard
Christopher J. Grimaldi
Austin L. Gurney
Victoria Smith
Jean-Philippe Stephan
Colin K. Watanabe
William J. Wood
Zemin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27585542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2632702(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2000/030873 external-priority patent/WO2001040465A2/fr
Priority claimed from PCT/US2001/006520 external-priority patent/WO2001068848A2/fr
Priority claimed from PCT/US2001/017092 external-priority patent/WO2001092331A2/fr
Priority claimed from PCT/US2001/017800 external-priority patent/WO2001093983A1/fr
Priority claimed from PCT/US2001/019692 external-priority patent/WO2002000690A2/fr
Priority claimed from PCT/US2001/021066 external-priority patent/WO2002008288A2/fr
Priority claimed from PCT/US2001/021735 external-priority patent/WO2002008284A2/fr
Application filed by Individual filed Critical Individual
Publication of CA2632702A1 publication Critical patent/CA2632702A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002632702A 2000-09-01 2001-08-29 Polypeptides secretes transmembranaires et acides nucleiques codant pour ceux-ci Abandoned CA2632702A1 (fr)

Applications Claiming Priority (45)

Application Number Priority Date Filing Date Title
US22989600P 2000-09-01 2000-09-01
US60/229,896 2000-09-01
US23062100P 2000-09-05 2000-09-05
US60/230,621 2000-09-05
US23514700P 2000-09-22 2000-09-22
US60/235,147 2000-09-22
EPPCT/US00/30873 2000-11-10
PCT/US2000/030873 WO2001040465A2 (fr) 1999-11-30 2000-11-10 Compositions et procedes de traitement de maladies d'ordre immunologique
US26187801P 2001-01-12 2001-01-12
US60/261,878 2001-01-12
US26215001P 2001-01-16 2001-01-16
US26191001P 2001-01-16 2001-01-16
US26193901P 2001-01-16 2001-01-16
US60/261,939 2001-01-16
US60/261,910 2001-01-16
US60/262,150 2001-01-16
US26439501P 2001-01-25 2001-01-25
US60/264,395 2001-01-25
US26642101P 2001-02-02 2001-02-02
US60/266,421 2001-02-02
US26762301P 2001-02-09 2001-02-09
US60/267,623 2001-02-09
PCT/US2001/006520 WO2001068848A2 (fr) 2000-03-01 2001-02-28 Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
EPPCT/US01/06520 2001-02-28
US27439901P 2001-03-09 2001-03-09
US60/274,399 2001-03-09
US28098201P 2001-04-03 2001-04-03
US60/280,982 2001-04-03
US28212901P 2001-04-04 2001-04-04
US28219901P 2001-04-04 2001-04-04
US60/282,129 2001-04-04
US60/282,199 2001-04-04
US29058901P 2001-05-09 2001-05-09
US60/290,589 2001-05-09
PCT/US2001/017092 WO2001092331A2 (fr) 2000-05-30 2001-05-25 Compositions et methodes de traitement de maladies d'origine immune
EPPCT/US01/17092 2001-05-25
PCT/US2001/017800 WO2001093983A1 (fr) 2000-06-02 2001-06-01 Polypeptides secretes et transmembranaires et acides nucleiques codant lesdits polypeptides
USPCT/YS01/17800 2001-06-01
PCT/US2001/019692 WO2002000690A2 (fr) 2000-06-23 2001-06-20 Compositions et procedes de diagnostic et de traitement de troubles dont l'angiogenese
EPPCT/US01/19692 2001-06-20
EPPCT/US01/21066 2001-06-29
PCT/US2001/021066 WO2002008288A2 (fr) 2000-07-20 2001-06-29 Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
PCT/US2001/021735 WO2002008284A2 (fr) 2000-07-20 2001-07-09 Compositions et methodes diagnostiques et therapeutiques de troubles impliquant l'angiogenese
EPPCT/US01/21735 2001-07-09
CA002421056A CA2421056A1 (fr) 2000-09-01 2001-08-29 Polypeptide servant de marqueur diagnostique de presence de tumeurs du colon

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002421056A Division CA2421056A1 (fr) 2000-09-01 2001-08-29 Polypeptide servant de marqueur diagnostique de presence de tumeurs du colon

Publications (1)

Publication Number Publication Date
CA2632702A1 true CA2632702A1 (fr) 2002-03-28

Family

ID=27585542

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002421056A Abandoned CA2421056A1 (fr) 2000-09-01 2001-08-29 Polypeptide servant de marqueur diagnostique de presence de tumeurs du colon
CA002632702A Abandoned CA2632702A1 (fr) 2000-09-01 2001-08-29 Polypeptides secretes transmembranaires et acides nucleiques codant pour ceux-ci

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002421056A Abandoned CA2421056A1 (fr) 2000-09-01 2001-08-29 Polypeptide servant de marqueur diagnostique de presence de tumeurs du colon

Country Status (5)

Country Link
EP (1) EP1341814A2 (fr)
JP (2) JP4451059B2 (fr)
AU (2) AU2002216610A1 (fr)
CA (2) CA2421056A1 (fr)
WO (1) WO2002024888A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
DE69942782D1 (de) 1998-11-27 2010-10-28 Ucb Sa Zusammensetzungen und Verfahren zur Erhöhung der Knochenmineralisierung
CA2491610A1 (fr) * 1999-12-01 2001-06-07 Kevin P. Baker Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
JP2004520005A (ja) * 2000-06-19 2004-07-08 エフ．ホフマン−ラ　ロシュ　アーゲー オステオレビン遺伝子多型性
US7268223B2 (en) 2000-09-22 2007-09-11 Wyeth Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
US7094570B2 (en) 2003-03-11 2006-08-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
NZ527087A (en) 2001-01-12 2008-09-26 Genetics Inst Llc Type 2 cytokine receptor and nucleic acids encoding same
CA2454185A1 (fr) * 2001-07-19 2003-01-30 Innate Pharma Ntb-a, une molecule de surface impliquee dans l'activite des cellules tueuses naturelles
WO2003106657A2 (fr) 2002-06-14 2003-12-24 Stowers Institute For Medical Research Sequences nucleotidiques et sequences d'acides amines wise/sost
US7893218B2 (en) 2003-06-16 2011-02-22 Stowers Institute For Medical Research Antibodies that specifically bind SOST peptides
US7585501B2 (en) 2002-06-14 2009-09-08 Stowers Institute For Medical Research Compositions and methods for treating kidney disease
FR2844713A1 (fr) * 2002-09-25 2004-03-26 Exonhit Therapeutics Sa Nouvelle cible de l'angiogenese et utilisations
US7718787B2 (en) * 2002-10-18 2010-05-18 Lg Life Sciences Limited Gene families associated with cancers
EP1636270B1 (fr) 2003-06-16 2016-07-20 UCB Pharma S.A. Anticorps specifiques de la sclerostine et methodes permettant d'accroitre la mineralisation osseuse
US7592429B2 (en) 2005-05-03 2009-09-22 Ucb Sa Sclerostin-binding antibody
US8003108B2 (en) 2005-05-03 2011-08-23 Amgen Inc. Sclerostin epitopes
CL2008002775A1 (es) 2007-09-17 2008-11-07 Amgen Inc Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
EP2494361B2 (fr) 2009-10-26 2019-01-09 Externautics S.p.A. Marqueurs de tumeurs des ovaires et leurs méthodes d'utilisation
US8921058B2 (en) 2009-10-26 2014-12-30 Externautics Spa Prostate tumor markers and methods of use thereof
EP2383578A1 (fr) * 2010-04-30 2011-11-02 Externautics S.p.A. Marqueur de tumeur et procédés d'utilisation correspondants
SMT202000095T1 (it) 2010-05-14 2020-03-13 Amgen Inc Formulazioni di anticorpi anti-sclerostina ad alta concentrazione
US9133272B2 (en) 2011-03-01 2015-09-15 Amgen Inc. Bispecific binding agents
JP2014511842A (ja) 2011-03-25 2014-05-19 アムジエン・インコーポレーテツド 抗スクレロスチン抗体結晶およびその製剤
DK2739311T3 (en) 2011-08-04 2018-04-23 Amgen Inc Method of treating bone slit defects
EA036740B1 (ru) 2011-12-28 2020-12-15 Эмджен Инк. Способ увеличения высоты альвеолярного отростка посредством применения антител к склеростину
WO2014006100A1 (fr) 2012-07-05 2014-01-09 Ucb Pharma S.A. Traitement de maladies osseuses
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
EA031025B1 (ru) 2012-12-21 2018-11-30 Сиэтл Дженетикс, Инк. Антитела против ntb-a и связанные с ними композиции и способы
MA41142A (fr) 2014-12-12 2017-10-17 Amgen Inc Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement
GB201604124D0 (en) 2016-03-10 2016-04-27 Ucb Biopharma Sprl Pharmaceutical formulation
CN119241705A (zh) 2018-03-30 2025-01-03 安姆根有限公司 C末端抗体变体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
US5824504A (en) * 1996-09-26 1998-10-20 Elshourbagy; Nabil A. Human 7-transmembrane receptor and DNA
WO1998039448A2 (fr) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 nouvelles proteines secretees
CA2285554A1 (fr) * 1997-03-25 1998-10-01 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
DE19817557A1 (de) * 1998-04-09 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe
CA2328895A1 (fr) * 1998-06-02 1999-12-09 Genentech, Inc. Proteines membranaires et acides nucleiques codant ces proteines
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JP2004522402A (ja) * 1999-06-02 2004-07-29 ジェネンテック・インコーポレーテッド 同一のものをコードする分泌及び膜貫通ポリペプチドと核酸

Also Published As

Publication number Publication date
AU1661002A (en) 2002-04-02
AU2002216610A1 (en) 2002-04-02
WO2002024888A3 (fr) 2003-07-03
JP4451059B2 (ja) 2010-04-14
WO2002024888A2 (fr) 2002-03-28
EP1341814A2 (fr) 2003-09-10
JP2004526412A (ja) 2004-09-02
CA2421056A1 (fr) 2002-03-28
JP2006223304A (ja) 2006-08-31

Similar Documents

Publication Publication Date Title
CA2632702A1 (fr) Polypeptides secretes transmembranaires et acides nucleiques codant pour ceux-ci
US7589172B2 (en) PRO256 polypeptides
US7297333B2 (en) Anti-PRO10268 antibodies
US7304126B2 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7504480B2 (en) PRO10275 polypeptides
US20060073552A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20060073555A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2378403A1 (fr) Nouveaux polynucleotides et technique d'utilisation de ceux-ci
EP1309620A2 (fr) Compositions et procedes de diagnose et traitement de maladies faisant intervenir l'angiogenese
AU2004237842B2 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2373915A1 (fr) Procedes et compositions visant a inhiber la proliferation des cellules cancereuses
WO2002008284A2 (fr) Compositions et methodes diagnostiques et therapeutiques de troubles impliquant l'angiogenese
CA2384089A1 (fr) Acides nucleiques et polypeptides du facteur 19 de croissance du fibroblaste, et procedes d'utilisation dans le traitement de l'obesite
NZ536320A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6740520B2 (en) Cytokine receptor and nucleic acids encoding the same
US7728108B2 (en) PRO1550 polypeptides
US20060073558A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7332578B2 (en) Anti-pro4407 antibodies
US20060073549A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7238790B2 (en) PRO1313 polypeptides
US7795412B2 (en) Nucleic acids encoding PRO6308 polypeptides and related vectors and host cells
US20060073556A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2003213166A1 (en) Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
US20060074228A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20060073554A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued